Phase 2a study of AZD-8601 in heart failure patients undergoing coronary artery bypass grafting (CABG) surgery.
Phase of Trial: Phase II
Latest Information Update: 21 Sep 2017
At a glance
- Drugs AZD 8601 (Primary)
- Indications Cardiovascular disorders
- Focus Therapeutic Use
- 21 Sep 2017 New trial record
- 14 Sep 2017 According to a Moderna Therapeutics media release, AstraZeneca has submitted a Clinical Trial Application (CTA) in Europe to initiate this study.